Format

Send to

Choose Destination
Andrologia. 2016 Jun;48(5):584-94. doi: 10.1111/and.12490. Epub 2015 Oct 1.

In vitro toxicity assay of cisplatin on mouse acute lymphoblastic leukaemia and spermatogonial stem cells.

Author information

1
Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.
2
Department of Anatomical Sciences, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
3
Department of Medical Nanotechnology and Faculty of Advanced Technology in Medicine, Iran University of Medical Sciences, Tehran, Iran.
4
Department of Medical Genetics and Molecular Biology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
5
Primegen Biotech LLC, Santa Ana, CA, USA.
6
Department of Statistics and Epidemiology, Faculty of Health, Tabriz Health Services Management Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
7
Chemical Engineering Department, Faculty of Engineering, University of Kashan, Kashan, Iran.
8
Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Abstract

Testicular cancer is the most common cancer affecting men in reproductive age, and cisplatin is one of the major helpful chemotherapeutic agents for treatment of this cancer. In addition, exposure of testes cancer cells to cisplatin could potentially eliminate tumour cells from germ cells in patients. The aim of this study was to evaluate the effect of cisplatin on viability of mouse acute lymphoblastic leukaemia cell line (EL-4) and neonatal mouse spermatogonial cells in vitro. In this study, the isolated spermatogonial stem cells (SSC) and EL-4 were divided into six groups including control (received medium), sham (received DMSO in medium) and experimental groups which received different doses of cisplatin (0.5, 5, 10 and 15 μg ml(-1) ). Cells viability was evaluated with MTT assay. The identity of the cultured cells was confirmed by the expression of specific markers. Our finding showed that viability of both SSC and EL-4 cells was reduced with the dose of 15 μg/ml when compared to the control group (P ≤ 0.05). Also, the differences between the IC50 in doses 10 and 15 μg/ml at different time were significant (P ≤ 0.05). The number of TUNEL-positive cells was increased, and the BAX and caspase-3 expressions were upregulated in EL4 cells for group that received an effective dose of cisplatin). In conclusion, despite the dramatic effects of cisplatin on both cells, spermatogonial stem cells could form colony in culture.

KEYWORDS:

Cisplatin; EL4 cells; SSCs; TUNEL assay; viability

PMID:
26428408
DOI:
10.1111/and.12490
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center